Protein biomarkers in cardiovascular disease: from the discovery to clinical implementation

We would like to invite you to Olink seminar/hybrid event at 13:30 CET on 24th March, at Erasmus MC Rotterdam, “Protein biomarkers in cardiovascular disease: from the discovery to clinical implementation.” The location is OWR-35, (Onderwijsruimte 35) Education center, Erasmus MC, Rotterdam or attend virtually!

Cardiovascular disease is the leading cause of death globally. It is crucial to identify at-risk individuals early on, deliver more precise and targeted therapy, reduce risk of recurrent CVD events. In this seminar you will learn how protein biomarkers help to better understand pathophysiology of heart failure and atrial fibrillation, predict disease progression or recurrence of CVD events. We will discuss future and perspectives of implementation of protein biomarkers into clinical practice to optimize decision-making and therapeutic management.


We only have limited spaces for the in person event, and you will receive an email confirming your place week beginning 14th March 2022. If you prefer to watch virtually, you will receive a link also in the week beginning 14th March 2022.



Isabella Kardys MD PhD FESC

Associate prof. Erasmus MC, Rotterdam
“Serial proteomics in heart failure for prognostication and subphenotyping”


Vicente Artola Arita MD

UMC Groningen
“Omics in atrial fibrillation”


Nick Nurmohamed, MD

AMC Amsterdam
“Targeted proteomics improves cardiovascular risk prediction”

Other upcoming events

HUPO 2022 Congress

  • Events
  • Cancun International Convention Center | Cancún, MX

San Antonio Breast Cancer Symposium (SABCS) 2022

  • Events
  • Henry B. Gonzalez Convention Center | San Antonio, TX, USA


Biomarker assays

~881 million

Protein data points generated


Publications listed on website

Contact us!